To clarify the mechanism by which LILRB4 promotes bone lesion of multiple myeloma, we used cytokine arrays to identify the differentially expressed cytokines in the CM from LILRB4-WT and -KO cells. This evidence concerns the gene LILRB4 and plasma cell myeloma.